Corrigendum to: ``The immune landscape of chondrosarcoma reveals an immunosuppressive environment in the dedifferentiated subtypes and exposes CSFR1+ macrophages as a promising therapeutic target.'' J Bone Oncol. 2020 Feb; 20: 100271

• Iseulys Richert,
• Anne Gomez-Brouchet,
• Corinne Bouvier,
• Gonzague Du Bouexic De Pinieux,
• arie KaranianM,
• Jean-Yves Blay,
• Aurélie Dutour

Affiliations

Iseulys Richert

CRCL, Cell death and pediatric cancers team, U1052, UMR5286 Lyon, France

Anne Gomez-Brouchet

Department of Pathology, IUCT-Oncopole, CHU of Toulouse, Université de Toulouse 3. UMR1037 INSERM-Université Toulouse 3-ERL5294 CNRS, Toulouse, France

Corinne Bouvier

Department of pathology, APHM La Timone, Aix Marseille University, MMG, France

Gonzague Du Bouexic De Pinieux

Department of pathology, Centre Hospitalier Universitaire Tours, 37000 Tours, France

arie KaranianM

Department of pathology, Centre Léon Bérard, Lyon, France

Jean-Yves Blay

CRCL, Cell death and pediatric cancers team, U1052, UMR5286 Lyon, France; Department of pathology, Centre Léon Bérard, Lyon, France

Aurélie Dutour

CRCL, Cell death and pediatric cancers team, U1052, UMR5286 Lyon, France; Corresponding author.